July 8, 2015
Healthcare experts are pushing for the recognition and treatment of “aging” as a “disease,” for regulatory purposes, in order to save the U.S. healthcare system, says Patrick Cox in an open letter published in Mauldin Economics. Anti-aging treatments have the potential of not only treating and potentially eliminating age-related diseases and other ailments but also improving quality of life, which results in less stress on the healthcare system as a whole. We are living in an era where breakthroughs in nanotechnology, genomics, biotechnology, robotics, epigenetics, neurotechnology and other sectors are geared toward enhancing the condition of the human body, especially its health and longevity. An improved body will not require as many trips to the oncologist, ophthalmologist, rheumatologist and other specialists. Recognition of anti-aging research, development and therapy applications is a necessary investment for a healthier medical system. As the old-age saying goes, a stitch in time, saves nine.